Science Corporation raises $400M Series D at $3.5B valuation
Start here
Science Corporation has raised a $400 million Series D round at a $3.5 billion valuation, according to a person familiar with the deal who spoke to TechCrunch. Investors in the round included Khosla Ventures, the Ackman Oxman Institute, Tenet Healthcare, 885 Capital, Y Combinator and PLC Neurotech. The company's first product, PRIMA, is a wearable and implantable chip intended to help people with age-related macular degeneration recover some vision. It is approved in Europe and available in Germany. CEO Max Hodak said at TechCrunch Disrupt that PRIMA is now being trialled for Stargardt's disease.
Generated from reports · updated 7 h ago
Report timeline
Follow the reports to see the event from different sides.
- TechCrunch · AIScience Corporation raises $400M Series D at $3.5 billion valuation
5 billion valuation, a person familiar with the deal told TechCrunch. Backers included Khosla Ventures, the Ackman Oxman Institute, Tenet Healthcare, 885 Capital, Y Combinator and PLC Neurotech. Its first product, PRIMA, a wearable and implantable chip that helps people with age-related macular degeneration recover some vision, is approved in Europe and available in Germany, and Hodak said at TechCrunch Disrupt it is now being trialled for Stargardt's disease.
Heat for this event
- Current, comparable range
- 8
- Peak, comparable range
- 10November 17 23:00
- Change in 24 hours
- –
The trend compares the same participants over hours observed continuously, so its range can be narrower than the current heat count. Hover or tap the chart for hourly heat; the arrow keys move through it.